Kiniksa Pharmaceuticals International Operating Margin Growth & History (KNSA)

Kiniksa Pharmaceuticals International's operating margin was 11.40% for fiscal 2025.

View full Kiniksa Pharmaceuticals International company overview

Kiniksa Pharmaceuticals International annual operating margin history

Kiniksa Pharmaceuticals International annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20252025-12-3111.40%+22.17 pp
20242024-12-31−10.78%−1.45 pp
20232023-12-31−9.32%−13.76 pp
20222022-12-314.44%+410.82 pp
20212021-12-31−406.38%

Kiniksa Pharmaceuticals International operating margin trends

Across the available reported history, Kiniksa Pharmaceuticals International's operating margin increased from −10.78% to 11.40%, a change of +22.17 percentage points. The latest reported quarter, Q1 2026, shows 13.66%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Kiniksa Pharmaceuticals International filings at SEC.gov ↗